Saskia J. Santegoets

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Alfons JM van den Eertwegh, Jurjen Versluis, H. Pieter van den Berg et al. · The Lancet Oncology · 2012 · 357 citations

Medicine, Immunology, Oncology +16

NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines

Nadine van Montfoort, Linda Borst, Michael Korrer et al. · Cell · 2018 · 327 citations · Full text

Life Sciences, Immunology, Oncology +12

Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses

Marij J.P. Welters, Tetje C. van der Sluis, Hélène van Meir et al. · Science Translational Medicine · 2016 · 210 citations

Medicine, Immunology, Oncology +17

Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry

Saskia J. Santegoets, Eveline M. Dijkgraaf, Alessandra Battaglia et al. · Cancer Immunology Immunotherapy · 2015 · 203 citations · Full text

Life Sciences, Immunology, Oncology +17

A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer

E. M. Dijkgraaf, Saskia J. Santegoets, A.K.L. Reyners et al. · Annals of Oncology · 2015 · 193 citations

Medicine, Oncology, Pharmacology +14